SCHEMBL19022015

SCHEMBL19022015

CCNC(=O)CC1CCN(C)C1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
BCHE P06276 1/20 0.39
KMT2A Q03164 1/20 0.38
USP30 Q70CQ3 1/20 0.37
EPHX1 P07099 1/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
NCF1 P14598 1/20 0.35
GNAI3 P08754 1/20 0.35
GNAO1 P09471 1/20 0.35
GNAI1 P63096 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10274873 0.91 KEAP1 (0.48) KEAP1NFE2L2BCHEKMT2AEPHX1
SCHEMBL19022011 0.90 KEAP1 (0.42) KEAP1NFE2L2BCHEKMT2AEPHX1
SCHEMBL19022017 0.87 KMT2A (0.38) KEAP1NFE2L2BCHEKMT2A
SCHEMBL26343654 0.86 KEAP1 (0.45) KEAP1NFE2L2USP30EPHX1ALDH1A1
SCHEMBL19010250 0.81 MAP4K4 (0.38) KEAP1NFE2L2BCHEEPHX1NCF1
SCHEMBL23894161 0.80 NCF1 (0.36) KEAP1NFE2L2USP30EPHX1NCF1
SCHEMBL12252175 0.78
SCHEMBL19000036 0.77 CHRM5 (0.40) KEAP1NFE2L2KMT2AALDH1A1
SCHEMBL26343670 0.77 KEAP1 (0.46) KEAP1NFE2L2USP30EPHX1ALDH1A1
SCHEMBL2558996 0.77 NCF1 (0.43) ALDH1A1NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106607-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed